Aurisco pharmaceutical Co., Ltd was established in 1998, focusing on APls development, manufacturing and marketing. We have filed 25+ API DMFs in US FDA as well as other regions (EU, Japan, Brazil , Korea and etc ) .Our production sites receive regular inspections from China, US FDA, EU and other stringent authorities. Product segments cover :
Small molecular drugs
Peptides
Oligonucleotides (ASO,,siRNA, Aptamer, CpG and etc)
Delivery system: Lipid, GalNAc